Cat. No. 3392
Biological ActivityReversed amino acid sequence control peptide for SLIGKV-NH2 (Cat. No. 3010), a protease-activated receptor 2 (PAR2) agonist.
(Modifications: Ser-6 = C-terminal amide)
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Lin et al (2008) Protease-activated receptor-2 (PAR-2) is a weak enhancer of mucin secretion by human bronchial epithelial cells in vitro. Int.J.Biochem.Cell Biol. 40 1379. PMID: 18077203.
Huang (2007) Protease-activated receptor-1 (PAR1) and PAR2 but not PAR4 mediate relaxations in lower esophageal sphincter. Regul.Pept. 142 37. PMID: 17335921.
Tognetto et al (2000) Evidence that PAR-1 and PAR-2 mediate prostanoid-dependent contraction in isolated guinea-pig gallbladder. Br.J.Pharmacol. 131 689. PMID: 11030717.
If you know of a relevant reference for VKGILS-NH2 please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses VKGILS-NH2 from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: VKGILS-NH2, supplier, Control, peptide, SLIGKV-NH2, PAR, Receptors, Protease-Activated, proteinase-activated, Tocris Bioscience, Protease-Activated Receptor Agonist products
Find multiple products by catalog number
New Products in this Area
Reverse analog of BradykininTASP 0390325
Potent and selective V1B receptor antagonist; orally bioavailableML 233
Non-peptide apelin receptor agonistBML 111
FPR2 (lipoxin A4 receptor) agonistAmylin (rat)
Potent endogenous peptide agonist for amylin, calcitonin, CGRP and adrenomedullin receptorsCalcitonin (human)
Endogenous calcitonin receptor agonist; inhibits bone resorptionSpexin
Potent GAL2/3 agonist; exhibits anxiolytic effects in vivoMM 54
Potent apelin receptor antagonist
Follow Tocris on LinkedIn
Visit our LinkedIn page for the latest Tocris news, events and updates.